1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Special Meeting of Stockholders Held; Voting Results Disclosed
Other Events
Announces 510(k) Clearance for LioraTM Monofilament Scaffold for Soft Tissue Reinforcement
TELA Bio, Inc. Enters Limited Consent to Credit Agreement with Perceptive
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces COO / CFO Transition and Strategic Cost Reduction Initiative
Amended material disclosure
Reports Second Quarter 2026 Financial Results
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership